×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Cara Therapeutics Inc. (CARA) NASDAQ

$0.24 (0.01) (-4.71%)

Market Cap: $13.26M

As of 06/18/24 04:00 PM EDT. Market closed.

(CARA)

Cara Therapeutics Inc. (CARA)
NASDAQ

$0.24
(0.01) (-4.71%)

Market Cap: $13.26M

As of 06/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

cara therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. cara's most advanced patented compound, cr845, is currently undergoing clinical testing for acute pain and ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$542,100
CEO Compensation (Total)
$2.79M
URL
Address
4 Stamford Plz, Connecticut, Stamford, 06902-3834.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Derek Chalmers
CEO Compensation (Base)
$542,100
CEO Compensation (Total)
$2.79M
Address
4 Stamford Plz, Connecticut, Stamford, 06902-3834.
PRICE CHART FOR CARA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.28
Previous Close
$0.25
Days Range
$0.24 - $0.27
52 week range
$0.24 - $4.45
Volume
1,382,343
Avg. Volume (30 days)
830,529
Market Cap
$13.26M
Dividend Yield
-
P/E
(0.11)
Shares Outstanding
54,675,954
Open
$0.28
Previous Close
$0.25
Days Range
$0.24 - $0.27
52 week range
$0.24 - $4.45
Volume
1,382,343
Avg. Volume (30 days)
830,529
Market Cap
$13.26M
Dividend Yield
-
P/E
(0.11)
Shares Outstanding
54,675,954
FINANCIAL STATEMENTS FOR CARA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CARA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Posner ChristopherPRESIDENT AND CEOMay 02, 2024 Sale$0.753,9362,952176,585May 06, 2024, 04:15 PM
Goncalves JoanaCHIEF MEDICAL OFFICERApr 05, 2024 Sale$0.832,7532,28553,365Apr 09, 2024, 04:22 PM
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Apr 05, 2024 Sale$0.832,7532,28588,247Apr 09, 2024, 04:21 PM
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Feb 29, 2024 Sale$0.893,2932,93191,000Mar 04, 2024, 04:24 PM
Posner ChristopherPRESIDENT AND CEOFeb 29, 2024 Sale$0.895,8345,192180,521Mar 04, 2024, 04:19 PM
Goncalves JoanaCHIEF MEDICAL OFFICERFeb 29, 2024 Sale$0.893,2932,93156,118Mar 04, 2024, 04:13 PM
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Feb 08, 2023 Sale$0.537,7704,11894,293Feb 12, 2024, 05:16 PM
Maynard Ryan DCHIEF FINANCIAL OFFICERFeb 08, 2023 Sale$0.535,4882,9098,012Feb 12, 2024, 05:15 PM
Goncalves JoanaCHIEF MEDICAL OFFICERFeb 08, 2023 Sale$0.537,7704,11859,411Feb 12, 2024, 05:13 PM
Posner ChristopherPRESIDENT AND CEOFeb 08, 2024 Sale$0.5335,57518,855186,355Feb 12, 2024, 05:10 PM
Posner ChristopherPRESIDENT AND CEOFeb 01, 2024 Sale$0.554,9812,740221,930Feb 05, 2024, 04:26 PM
Posner ChristopherPresident and CEONov 02, 2023 Sale$1.223,7964,631164,411Nov 03, 2023, 04:37 PM
Posner ChristopherPresident and CEOAug 03, 2023 Sale$3.074,30713,222168,207Aug 04, 2023, 05:21 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Jun 23, 2023 Sale$3.512,4838,71588,563Jun 27, 2023, 04:09 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DJun 23, 2023 Sale$3.512,99310,505153,747Jun 27, 2023, 04:08 PM
Goncalves JoanaChief Medical OfficerJun 23, 2023 Sale$3.512,7239,55853,681Jun 27, 2023, 04:07 PM
Posner ChristopherPresident and CEOMay 05, 2023 Sale$4.403,86917,024172,514May 09, 2023, 04:22 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Apr 04, 2023 Sale$4.912,48112,18291,046Apr 06, 2023, 05:14 PM
Goncalves JoanaChief Medical OfficerApr 04, 2023 Sale$4.912,48112,18256,404Apr 06, 2023, 05:13 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DApr 04, 2023 Sale$4.912,73313,419156,740Apr 06, 2023, 05:12 PM
Posner ChristopherPresident and CEOMar 03, 2023 Sale$9.715,98758,134176,383Mar 07, 2023, 04:47 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DMar 03, 2023 Sale$9.716,80266,047159,473Mar 07, 2023, 04:46 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Mar 03, 2023 Sale$9.716,25660,74693,527Mar 07, 2023, 04:44 PM
Goncalves JoanaChief Medical OfficerMar 03, 2023 Sale$9.716,22160,40658,885Mar 07, 2023, 04:43 PM
Goncalves JoanaChief Medical OfficerFeb 16, 2023 Sale$10.202,26523,10365,106Feb 17, 2023, 04:27 PM
Posner ChristopherPresident and CEOFeb 02, 2023 Sale$11.804,19149,454182,370Feb 03, 2023, 06:38 PM
Goncalves JoanaChief Medical OfficerJan 17, 2023 Sale$10.812,26524,48567,371Jan 19, 2023, 04:18 PM
Goncalves JoanaChief Medical OfficerDec 29, 2022 Sale$10.182,26523,05869,636Jan 03, 2023, 04:32 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DDec 21, 2022 Sale$11.273,50639,513166,275Dec 23, 2022, 04:54 PM
Goncalves JoanaChief Medical OfficerDec 21, 2022 Sale$11.272,99233,72071,901Dec 23, 2022, 04:53 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Dec 21, 2022 Sale$11.272,56128,86299,783Dec 23, 2022, 04:52 PM
Posner ChristopherPresident and CEONov 16, 2022 Sale$11.1314,470161,051186,561Nov 18, 2022, 05:23 PM
VOGELBAUM MARTINDirectorSep 14, 2022 Sale$10.2810,800111,02444,988Sep 16, 2022, 04:21 PM
Ives Jeffrey L.DirectorJul 15, 2022 Sale$9.053,60032,58015,476Jul 19, 2022, 05:16 PM
BAINS HARRISON M JRDirectorJul 15, 2022 Sale$9.057,20065,16025,076Jul 19, 2022, 05:13 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Apr 01, 2022 Sale$11.911,64219,556102,344Apr 05, 2022, 05:51 PM
Goncalves JoanaChief Medical OfficerApr 01, 2022 Sale$11.911,64219,55674,893Apr 05, 2022, 05:50 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DApr 01, 2022 Sale$11.911,78421,247169,781Apr 05, 2022, 05:49 PM
Posner ChristopherPresident and CEOApr 04, 2022 Sale$12.672,00625,416201,031Apr 05, 2022, 05:48 PM
Reilly Thomas CharlesChief Financial OfficerMar 03, 2022 Sale$11.382,04423,26137,811Mar 04, 2022, 05:54 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Mar 03, 2022 Sale$11.381,78720,336103,986Mar 04, 2022, 05:51 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Feb 25, 2022 Sale$10.291,97220,292100,440Mar 01, 2022, 04:19 PM
Ives Jeffrey L.DirectorNov 12, 2021 Sale$16.048,180131,2077,200Nov 16, 2021, 06:15 PM
Goncalves JoanaChief Medical OfficerNov 01, 2021 Sale$17.151,00017,15045,900Nov 03, 2021, 04:55 PM
Goncalves JoanaChief Medical OfficerOct 27, 2021 Sale$15.001,00015,00046,900Oct 28, 2021, 06:34 PM
CHALMERS DEREK TPresident & CEOSep 07, 2021 Sale$15.4720,000309,400991,405Sep 09, 2021, 04:48 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Aug 30, 2021 Sale$14.201,75924,97870,917Sep 01, 2021, 06:09 PM
Reilly Thomas CharlesChief Financial OfficerAug 30, 2021 Sale$14.201,98228,1443,352Sep 01, 2021, 06:08 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DAug 30, 2021 Sale$14.203,84754,627141,072Sep 01, 2021, 06:07 PM
Goncalves JoanaChief Medical OfficerAug 30, 2021 Sale$14.202,11029,96247,900Sep 01, 2021, 06:06 PM
CHALMERS DEREK TPresident & CEOAug 30, 2021 Sale$14.208,440119,8481,011,405Sep 01, 2021, 06:04 PM
VOGELBAUM MARTINDirectorJun 07, 2021 Sale$13.058,640112,75220,160Jun 07, 2021, 07:35 PM
Posner ChristopherDirectorJun 07, 2021 Sale$13.042,30430,04416,096Jun 07, 2021, 07:33 PM
Ives Jeffrey L.DirectorJun 07, 2021 Sale$13.052,52032,88615,380Jun 07, 2021, 07:25 PM
Goncalves JoanaChief Medical OfficerApr 21, 2021 Sale$27.633,00082,89043,610Apr 23, 2021, 05:05 PM
Goncalves JoanaChief Medical OfficerMar 22, 2021 Sale$19.653,00058,95030,610Mar 24, 2021, 05:55 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DMar 05, 2021 Sale$17.983,35860,377119,319Mar 08, 2021, 05:48 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Mar 05, 2021 Sale$17.983,09055,55851,342Mar 08, 2021, 05:47 PM
Goncalves JoanaChief Medical OfficerMar 05, 2021 Sale$17.983,09355,61233,610Mar 08, 2021, 05:45 PM
CHALMERS DEREK TPresident & CEOMar 05, 2021 Sale$17.983,10355,792950,511Mar 08, 2021, 05:44 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Feb 25, 2021 Sale$19.334,00477,39744,432Feb 25, 2021, 09:06 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DFeb 25, 2021 Sale$19.335,00396,708112,677Feb 25, 2021, 09:05 PM
Goncalves JoanaChief Medical OfficerFeb 25, 2021 Sale$19.333,37265,18126,703Feb 25, 2021, 09:04 PM
CHALMERS DEREK TPresident & CEOFeb 25, 2021 Sale$19.3311,729226,722943,614Feb 25, 2021, 09:02 PM
Goncalves JoanaChief Medical OfficerFeb 22, 2021 Sale$19.732,00039,46026,075Feb 24, 2021, 05:02 PM
Goncalves JoanaChief Medical OfficerJan 21, 2021 Sale$20.122,00040,24028,075Jan 25, 2021, 05:32 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Dec 30, 2020 Sale$15.301,94629,77442,436Dec 30, 2020, 06:16 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DDec 30, 2020 Sale$15.302,81243,024109,680Dec 30, 2020, 06:15 PM
Goncalves JoanaChief Medical OfficerDec 30, 2020 Sale$15.301,29819,85930,075Dec 30, 2020, 06:14 PM
CHALMERS DEREK TPresident & CEODec 30, 2020 Sale$15.306,07892,993936,593Dec 30, 2020, 06:12 PM
CHALMERS DEREK TPresident & CEODec 28, 2020 Sale$16.005,00080,000942,671Dec 29, 2020, 06:41 PM
Goncalves JoanaChief Medical OfficerDec 21, 2020 Sale$15.002,00030,00027,373Dec 23, 2020, 07:11 PM
CHALMERS DEREK TPresident & CEODec 16, 2020 Sale$14.955,00074,750928,921Dec 18, 2020, 04:58 PM
CHALMERS DEREK TPresident & CEODec 10, 2020 Sale$15.297,500114,675933,921Dec 11, 2020, 08:32 PM
Goncalves JoanaChief Medical OfficerNov 23, 2020 Sale$15.312,00030,62029,373Nov 25, 2020, 04:48 PM
Ives Jeffrey L.DirectorNov 19, 2020 Sale$15.752,50039,37210,700Nov 24, 2020, 05:46 PM
Posner ChristopherDirectorNov 19, 2020 Sale$15.822,00031,63811,200Nov 23, 2020, 08:28 PM
Ives Jeffrey L.DirectorNov 19, 2020 Option Exercise$15.752,50039,37210,700Nov 23, 2020, 08:26 PM
VOGELBAUM MARTINDirectorNov 17, 2020 Sale$16.096,00096,54014,400Nov 19, 2020, 05:30 PM
CHALMERS DEREK TPresident & CEONov 17, 2020 Sale$16.0011,799188,784941,421Nov 19, 2020, 05:29 PM
Goncalves JoanaChief Medical OfficerNov 10, 2020 Sale$15.002,00030,00031,373Nov 13, 2020, 05:39 PM
Goncalves JoanaChief Medical OfficerOct 20, 2020 Sale$15.002,00030,00033,373Oct 22, 2020, 06:00 PM
CHALMERS DEREK TPresident & CEOSep 03, 2020 Sale$16.003,20151,216953,220Sep 08, 2020, 05:22 PM
CHALMERS DEREK TPresident & CEOAug 03, 2020 Sale$16.425,00082,100956,421Aug 05, 2020, 06:20 PM
CHALMERS DEREK TPresident & CEOJul 01, 2020 Sale$17.115,00085,550961,421Jul 02, 2020, 04:40 PM
Goncalves JoanaChief Medical OfficerJun 12, 2020 Sale$15.2010,627161,53035,373Jun 12, 2020, 06:00 PM
CHALMERS DEREK TPresident & CEOJun 03, 2020 Sale$16.014,30068,843966,421Jun 03, 2020, 07:53 PM
CHALMERS DEREK TPresident & CEOJun 01, 2020 Sale$16.0070011,200970,721Jun 03, 2020, 07:53 PM
Ives Jeffrey L.DirectorJun 01, 2020 Option Exercise$9.941,0009,9407,000Jun 03, 2020, 07:51 PM
Ives Jeffrey L.DirectorJun 01, 2020 Sale$16.001,00016,0006,000Jun 03, 2020, 07:51 PM
CHALMERS DEREK TPresident & CEOMay 21, 2020 Sale$16.003,50056,000971,792May 22, 2020, 06:26 PM
CHALMERS DEREK TPresident & CEOMay 20, 2020 Sale$16.001,20019,200975,292May 22, 2020, 06:26 PM
CHALMERS DEREK TPresident & CEOMay 22, 2020 Sale$16.003715,936971,421May 22, 2020, 06:26 PM
CHALMERS DEREK TPresident & CEOMay 12, 2020 Sale$16.004,92978,864976,492May 14, 2020, 08:04 PM
Ives Jeffrey L.DirectorMay 12, 2020 Option Exercise$9.942,50024,8508,500May 14, 2020, 08:02 PM
Ives Jeffrey L.DirectorMay 12, 2020 Sale$16.002,50040,0006,000May 14, 2020, 08:02 PM
Ives Jeffrey L.DirectorApr 21, 2020 Option Exercise$9.942,50024,8508,500Apr 21, 2020, 07:09 PM
Ives Jeffrey L.DirectorApr 21, 2020 Sale$16.002,50040,0006,000Apr 21, 2020, 07:09 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Apr 21, 2020 Sale$15.562,72142,33938,382Apr 21, 2020, 06:50 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DApr 21, 2020 Sale$15.5812,894200,889104,492Apr 21, 2020, 06:49 PM
CHALMERS DEREK TPresident & CEOApr 21, 2020 Sale$15.566,34898,775981,421Apr 21, 2020, 06:47 PM
Ives Jeffrey L.DirectorMar 04, 2020 Option Exercise$9.942,50024,8508,500Mar 06, 2020, 04:39 PM
Ives Jeffrey L.DirectorMar 04, 2020 Sale$16.002,50040,0006,000Mar 06, 2020, 04:39 PM
Ives Jeffrey L.DirectorFeb 03, 2020 Option Exercise$9.942,50024,8508,500Feb 05, 2020, 05:01 PM
Ives Jeffrey L.DirectorFeb 03, 2020 Sale$16.232,50040,5756,000Feb 05, 2020, 05:01 PM
Ives Jeffrey L.DirectorJan 02, 2020 Option Exercise$9.942,50024,8508,500Jan 06, 2020, 06:06 PM
Ives Jeffrey L.DirectorJan 02, 2020 Sale$16.132,50040,3256,000Jan 06, 2020, 06:06 PM
CHALMERS DEREK TPresident & CEOJan 02, 2020 Sale$16.0510,000160,500917,769Jan 06, 2020, 06:05 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Dec 04, 2019 Sale$17.053,98067,85916,769Dec 04, 2019, 07:52 PM
Mohindru ManiCFO & Chief Strategy OfficerDec 04, 2019 Sale$17.054,75581,07317,441Dec 04, 2019, 07:50 PM
Ives Jeffrey L.DirectorDec 02, 2019 Option Exercise$5.322,50013,3008,500Dec 04, 2019, 07:49 PM
Ives Jeffrey L.DirectorDec 02, 2019 Sale$25.832,50064,5756,000Dec 04, 2019, 07:49 PM
CHALMERS DEREK TPresident & CEODec 04, 2019 Sale$17.0510,699182,418927,769Dec 04, 2019, 07:47 PM
CHALMERS DEREK TPresident & CEODec 02, 2019 Sale$25.7910,000257,900918,468Dec 04, 2019, 07:47 PM
Ives Jeffrey L.DirectorNov 01, 2019 Option Exercise$5.322,50013,3008,500Nov 05, 2019, 06:21 PM
Ives Jeffrey L.DirectorNov 01, 2019 Sale$20.682,50051,7006,000Nov 05, 2019, 06:21 PM
CHALMERS DEREK TPresident & CEONov 01, 2019 Sale$20.795,000103,950928,468Nov 05, 2019, 06:07 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DOct 25, 2019 Sale$19.914,00079,64063,886Oct 29, 2019, 08:36 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DOct 18, 2019 Sale$19.334,00077,32067,886Oct 22, 2019, 05:01 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DOct 11, 2019 Sale$18.704,00074,80071,886Oct 16, 2019, 06:26 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DOct 04, 2019 Sale$19.194,00076,76075,886Oct 08, 2019, 04:44 PM
Ives Jeffrey L.DirectorOct 01, 2019 Option Exercise$5.322,50013,3008,500Oct 03, 2019, 09:19 PM
Ives Jeffrey L.DirectorOct 01, 2019 Sale$18.212,50045,5256,000Oct 03, 2019, 09:19 PM
CHALMERS DEREK TPresident & CEOOct 01, 2019 Sale$18.2810,000182,800933,468Oct 03, 2019, 09:17 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DSep 03, 2019 Sale$22.9220,000458,40079,886Sep 05, 2019, 05:38 PM
Ives Jeffrey L.DirectorSep 03, 2019 Option Exercise$5.322,50013,3008,500Sep 05, 2019, 05:37 PM
Ives Jeffrey L.DirectorSep 03, 2019 Sale$23.312,50058,2756,000Sep 05, 2019, 05:37 PM
CHALMERS DEREK TPresident & CEOSep 03, 2019 Sale$23.265,000116,300943,468Sep 05, 2019, 05:36 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DAug 01, 2019 Sale$23.2420,000464,80099,886Aug 05, 2019, 05:33 PM
Ives Jeffrey L.DirectorAug 01, 2019 Option Exercise$5.322,50013,3008,500Aug 05, 2019, 05:32 PM
Ives Jeffrey L.DirectorAug 01, 2019 Sale$23.242,50058,1006,000Aug 05, 2019, 05:32 PM
CHALMERS DEREK TPresident & CEOAug 01, 2019 Sale$23.2710,000232,700948,468Aug 05, 2019, 05:31 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DJul 17, 2019 Sale$27.508,996247,390119,886Jul 19, 2019, 05:47 PM
Mohindru ManiCFO & Chief Strategy OfficerJul 15, 2019 Option Exercise$14.0637,431526,28051,294Jul 17, 2019, 05:46 PM
Mohindru ManiCFO & Chief Strategy OfficerJul 15, 2019 Sale$25.0037,431935,77513,863Jul 17, 2019, 05:46 PM
Ives Jeffrey L.DirectorJul 01, 2019 Option Exercise$5.322,50013,3008,500Jul 03, 2019, 04:04 PM
Ives Jeffrey L.DirectorJul 01, 2019 Sale$21.752,50054,3756,000Jul 03, 2019, 04:04 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DJul 01, 2019 Sale$21.9020,000438,000128,882Jul 03, 2019, 03:59 PM
Terrillion ScottSec'y; Chief Compliance & G.C.May 29, 2019 Sale$21.382,30349,23812,416May 30, 2019, 06:19 PM
CHALMERS DEREK TPresident & CEOMay 29, 2019 Sale$21.425,528118,410958,468May 30, 2019, 06:18 PM
Mohindru ManiCFO & Chief Strategy OfficerMay 29, 2019 Sale$21.392,49653,38913,863May 30, 2019, 06:17 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DMay 29, 2019 Sale$21.1911,397241,502148,882May 30, 2019, 06:16 PM
Mohindru ManiCFO & Chief Strategy OfficerMar 13, 2019 Option Exercise$14.0616,041225,53624,067Mar 15, 2019, 04:42 PM
Mohindru ManiCFO & Chief Strategy OfficerMar 13, 2019 Sale$19.1216,041306,7048,026Mar 15, 2019, 04:42 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DMar 13, 2019 Sale$18.8716,803317,073122,779Mar 14, 2019, 05:13 PM
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&DMar 12, 2019 Sale$17.503,19755,948139,582Mar 14, 2019, 05:13 PM
CHALMERS DEREK TPresident & CEOMar 01, 2019 Sale$17.049,792166,856943,996Mar 05, 2019, 04:53 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentFeb 28, 2019 Sale$17.501,50026,250142,779Mar 04, 2019, 05:49 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentFeb 25, 2019 Sale$17.502,20038,500144,279Feb 27, 2019, 05:29 PM
CHALMERS DEREK TPresident & CEOFeb 01, 2019 Sale$14.9920,000299,800953,788Feb 05, 2019, 04:27 PM
CHALMERS DEREK TPresident & CEOJan 04, 2019 Sale$15.045,00075,200973,788Jan 04, 2019, 04:22 PM
CHALMERS DEREK TPresident & CEOJan 02, 2019 Sale$13.1315,000196,950978,788Jan 04, 2019, 04:22 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentDec 28, 2018 Sale$12.534,30053,879146,479Jan 02, 2019, 05:56 PM
Terrillion ScottSec'y; Chief Compliance & G.C.Dec 28, 2018 Sale$12.513,10038,7816,386Jan 02, 2019, 05:56 PM
CHALMERS DEREK TPresident & CEODec 28, 2018 Sale$12.5315,825198,287993,788Jan 02, 2019, 05:55 PM
Mohindru ManiCFO & Chief Strategy OfficerDec 28, 2018 Sale$12.554,50056,4758,026Jan 02, 2019, 05:54 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentDec 03, 2018 Sale$18.363,00055,080139,000Dec 06, 2018, 04:18 PM
CHALMERS DEREK TPresident & CEODec 03, 2018 Sale$18.1720,000363,400971,392Dec 06, 2018, 04:16 PM
Mohindru ManiCFO & Chief Strategy OfficerNov 15, 2018 Option Exercise$14.0616,042225,55116,042Nov 16, 2018, 04:22 PM
Mohindru ManiCFO & Chief Strategy OfficerNov 15, 2018 Sale$18.5016,042296,7770Nov 16, 2018, 04:22 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentNov 01, 2018 Option Exercise$2.0540,00082,000145,000Nov 05, 2018, 08:25 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentNov 01, 2018 Sale$18.773,00056,310142,000Nov 05, 2018, 08:25 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentAug 06, 2018 Option Exercise$2.2510,00022,500114,000Nov 05, 2018, 08:21 PM
CHALMERS DEREK TPresident & CEONov 01, 2018 Sale$18.7820,000375,600991,392Nov 02, 2018, 05:35 PM
Stauffer Joseph WilliamChief Medical OfficerOct 17, 2018 Sale$20.1311,442230,3472,970Oct 19, 2018, 04:34 PM
Mohindru ManiCFO & Chief Strategy OfficerOct 17, 2018 Option Exercise$14.0616,042225,55116,042Oct 19, 2018, 04:32 PM
Mohindru ManiCFO & Chief Strategy OfficerOct 17, 2018 Sale$20.1916,042323,8880Oct 19, 2018, 04:32 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentOct 01, 2018 Sale$23.993,00071,97095,000Oct 03, 2018, 04:09 PM
CHALMERS DEREK TPresident & CEOOct 01, 2018 Sale$23.7920,000475,8001,011,392Oct 03, 2018, 04:08 PM
CHALMERS DEREK TPresident & CEOSep 04, 2018 Sale$19.7120,000394,2001,031,392Sep 06, 2018, 05:34 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentSep 04, 2018 Sale$19.813,00059,43098,000Sep 06, 2018, 05:33 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentAug 20, 2018 Sale$18.893,00056,670101,000Aug 22, 2018, 05:26 PM
CHALMERS DEREK TPresident & CEOJul 10, 2018 Sale$20.6420,000412,8001,051,392Jul 12, 2018, 04:42 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentJul 02, 2018 Sale$19.003,00057,000104,000Jul 05, 2018, 05:00 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentJun 01, 2018 Sale$15.493,00046,470107,000Jun 05, 2018, 07:15 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentMay 23, 2018 Sale$15.199,000136,710110,000May 25, 2018, 04:22 PM
CHALMERS DEREK TPresident & CEOFeb 16, 2018 Sale$15.005,40081,0001,071,392Feb 21, 2018, 05:13 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentFeb 15, 2018 Sale$15.023,00045,060119,000Feb 20, 2018, 04:43 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentJan 24, 2018 Sale$15.0015,000225,000122,000Jan 26, 2018, 05:53 PM
CHALMERS DEREK TPresident & CEOJan 25, 2018 Option Exercise$6.003,00018,0001,076,792Jan 26, 2018, 05:52 PM
CHALMERS DEREK TPresident & CEOJan 24, 2018 Sale$15.0012,500187,5001,073,792Jan 26, 2018, 05:52 PM
Menzaghi Frederique Ph.D.Sr VP-Research & DevelopmentNov 07, 2017 Option Exercise$2.4820,00049,600137,000Nov 09, 2017, 04:36 PM
CHALMERS DEREK TPresident & CEONov 03, 2017 Option Exercise$2.4820,00049,6001,086,292Nov 03, 2017, 05:27 PM
CHALMERS DEREK TPresident & CEONov 01, 2017 Sale$12.6616,000202,5601,066,292Nov 03, 2017, 05:27 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentAug 04, 2017 Sale$15.003,00045,000117,000Aug 10, 2017, 05:47 PM
Schoell JosefChief Financial OfficerJul 26, 2017 Option Exercise$2.254,0009,00050,000Jul 28, 2017, 04:53 PM
CHALMERS DEREK TPresident & CEOJul 14, 2017 Option Exercise$2.4810,00024,8001,107,292Jul 18, 2017, 06:10 PM
CHALMERS DEREK TPresident & CEOJul 14, 2017 Sale$15.0525,000376,2501,082,292Jul 18, 2017, 06:10 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentJul 14, 2017 Sale$15.003,00045,000120,000Jul 18, 2017, 06:09 PM
Slagel DeanDirectorJun 29, 2017 Sale$25.87250,0006,468,5641,085,200Jul 03, 2017, 05:53 PM
RHO Ventures VI LP10% OwnerMar 31, 2017 Buy$18.19500,0009,095,7003,568,057Apr 03, 2017, 09:19 AM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentApr 20, 2016 Sale$9.006,00054,000123,000Apr 20, 2016, 05:34 PM
VOGELBAUM MARTINDirectorMar 17, 2016 Buy$4.93247,7271,221,3683,068,057Mar 18, 2016, 07:43 PM
VOGELBAUM MARTINDirectorMar 16, 2016 Buy$4.78152,273727,8342,820,330Mar 18, 2016, 07:43 PM
RHO Ventures VI LP10% OwnerMar 16, 2016 Buy$4.78152,273727,8342,820,330Mar 18, 2016, 07:22 PM
RHO Ventures VI LP10% OwnerMar 17, 2016 Buy$4.93247,7271,221,3683,068,057Mar 18, 2016, 07:22 PM
Schoell JosefChief Financial OfficerMar 16, 2016 Option Exercise$0.8218,00014,74046,000Mar 17, 2016, 08:22 PM
CHALMERS DEREK TPresident & CEOMar 15, 2016 Option Exercise$2.4810,00024,8001,097,292Mar 17, 2016, 05:59 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentFeb 03, 2016 Sale$9.001,0009,000129,000Feb 03, 2016, 04:41 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentFeb 01, 2016 Sale$9.055,00045,250130,000Feb 03, 2016, 04:41 PM
Lewis Michael EChief Scientific AdvisorJan 26, 2016 Sale$10.937,26279,374314,988Jan 27, 2016, 05:10 PM
Slagel DeanDirectorJan 05, 2016 Sale$17.0131,224531,1201,314,338Jan 12, 2016, 07:00 PM
Slagel DeanDirectorDec 31, 2015 Sale$17.0012,776217,1921,345,562Jan 12, 2016, 07:00 PM
CHALMERS DEREK TPresident & CEOJan 06, 2016 Sale$17.2212,500215,2501,087,292Jan 07, 2016, 08:31 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentJan 04, 2016 Sale$16.806,000100,800135,000Jan 05, 2016, 04:56 PM
Slagel DeanDirectorJan 05, 2016 Sale$17.0131,224531,1201,314,338Jan 05, 2016, 04:54 PM
Slagel DeanDirectorDec 31, 2015 Sale$17.0012,776217,1921,345,562Jan 05, 2016, 04:54 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentDec 01, 2015 Sale$16.216,00097,260141,000Dec 03, 2015, 05:17 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentNov 02, 2015 Sale$14.266,00085,560147,000Nov 03, 2015, 06:08 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentOct 01, 2015 Sale$13.956,00083,715154,500Oct 05, 2015, 04:57 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentSep 01, 2015 Sale$18.637,000130,410159,000Sep 03, 2015, 05:52 PM
Schoell JosefChief Financial OfficerAug 18, 2015 Buy$22.103,00066,30028,000Aug 19, 2015, 06:03 PM
Stauffer Joseph WilliamChief Medical OfficerAug 04, 2015 Buy$18.602,00037,20013,442Aug 06, 2015, 04:46 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentAug 03, 2015 Sale$21.417,000149,870166,000Aug 05, 2015, 05:16 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentJul 01, 2015 Sale$12.227,00085,540173,000Jul 06, 2015, 05:06 PM
Lewis Michael EChief Scientific AdvisorJul 01, 2015 Sale$11.667,26284,675322,250Jul 06, 2015, 05:03 PM
Lewis Michael EChief Scientific AdvisorJun 01, 2015 Sale$9.507,26268,989329,512Jun 02, 2015, 06:11 PM
Slagel DeanDirectorMay 18, 2015 Sale$10.0482,945832,7681,390,604May 19, 2015, 05:11 PM
Slagel DeanDirectorMay 15, 2015 Sale$10.0073,600736,0001,473,549May 19, 2015, 05:11 PM
Slagel DeanDirectorMay 19, 2015 Sale$10.0032,266322,6601,358,338May 19, 2015, 05:11 PM
Lewis Michael EChief Scientific AdvisorMay 01, 2015 Sale$10.647,26277,268336,774May 05, 2015, 04:49 PM
Lewis Michael EChief Scientific AdvisorApr 01, 2015 Sale$9.907,26271,894344,036Apr 02, 2015, 05:34 PM
Menzaghi Frederique Ph.D.VP-Research & DevelopmentMar 09, 2015 Option Exercise$0.2520,0005,000180,000Mar 11, 2015, 04:54 PM
Lewis Michael EChief Scientific AdvisorMar 02, 2015 Sale$10.117,26273,419351,298Mar 03, 2015, 06:42 PM
Schoell JosefChief Financial OfficerFeb 17, 2015 Sale$10.9615,000164,40025,000Feb 19, 2015, 06:00 PM
Lewis Michael EChief Scientific AdvisorFeb 02, 2015 Sale$10.607,26276,977358,560Feb 03, 2015, 05:35 PM
Stauffer Joseph WilliamChief Medical OfficerDec 01, 2014 Option Exercise$8.7411,442100,00311,442Dec 03, 2014, 07:23 PM
Schoell JosefChief Financial OfficerAug 14, 2014 Option Exercise$0.2540,00010,00040,000Aug 14, 2014, 06:24 PM
VOGELBAUM MARTINDirectorFeb 05, 2014 Buy$11.00225,8182,483,9982,668,057Feb 05, 2014, 05:17 PM
RHO Ventures VI LP10% OwnerFeb 05, 2014 Buy$11.00225,8182,483,9982,668,057Feb 05, 2014, 05:14 PM
ALTA BIOPHARMA PARTNERS III LP10% OwnerFeb 05, 2014 Buy$11.00112,8171,240,9871,753,447Feb 05, 2014, 04:54 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Posner ChristopherPRESIDENT AND CEO05/02/20242,952
Goncalves JoanaCHIEF MEDICAL OFFICER04/05/20242,285
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.04/05/20242,285
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.02/29/20242,931
Posner ChristopherPRESIDENT AND CEO02/29/20245,192
Goncalves JoanaCHIEF MEDICAL OFFICER02/29/20242,931
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.02/08/20234,118
Maynard Ryan DCHIEF FINANCIAL OFFICER02/08/20232,909
Goncalves JoanaCHIEF MEDICAL OFFICER02/08/20234,118
Posner ChristopherPRESIDENT AND CEO02/08/202418,855
Posner ChristopherPRESIDENT AND CEO02/01/20242,740
Posner ChristopherPresident and CEO11/02/20234,631
Posner ChristopherPresident and CEO08/03/202313,222
Terrillion ScottSec'y; Chief Compliance & G.C.06/23/20238,715
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D06/23/202310,505
Goncalves JoanaChief Medical Officer06/23/20239,558
Posner ChristopherPresident and CEO05/05/202317,024
Terrillion ScottSec'y; Chief Compliance & G.C.04/04/202312,182
Goncalves JoanaChief Medical Officer04/04/202312,182
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D04/04/202313,419
Posner ChristopherPresident and CEO03/03/202358,134
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D03/03/202366,047
Terrillion ScottSec'y; Chief Compliance & G.C.03/03/202360,746
Goncalves JoanaChief Medical Officer03/03/202360,406
Goncalves JoanaChief Medical Officer02/16/202323,103
Posner ChristopherPresident and CEO02/02/202349,454
Goncalves JoanaChief Medical Officer01/17/202324,485
Goncalves JoanaChief Medical Officer12/29/202223,058
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D12/21/202239,513
Goncalves JoanaChief Medical Officer12/21/202233,720
Terrillion ScottSec'y; Chief Compliance & G.C.12/21/202228,862
Posner ChristopherPresident and CEO11/16/2022161,051
VOGELBAUM MARTINDirector09/14/2022111,024
Ives Jeffrey L.Director07/15/202232,580
BAINS HARRISON M JRDirector07/15/202265,160
Terrillion ScottSec'y; Chief Compliance & G.C.04/01/202219,556
Goncalves JoanaChief Medical Officer04/01/202219,556
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D04/01/202221,247
Posner ChristopherPresident and CEO04/04/202225,416
Reilly Thomas CharlesChief Financial Officer03/03/202223,261
Terrillion ScottSec'y; Chief Compliance & G.C.03/03/202220,336
Terrillion ScottSec'y; Chief Compliance & G.C.02/25/202220,292
Ives Jeffrey L.Director11/12/2021131,207
Goncalves JoanaChief Medical Officer11/01/202117,150
Goncalves JoanaChief Medical Officer10/27/202115,000
CHALMERS DEREK TPresident & CEO09/07/2021309,400
Terrillion ScottSec'y; Chief Compliance & G.C.08/30/202124,978
Reilly Thomas CharlesChief Financial Officer08/30/202128,144
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D08/30/202154,627
Goncalves JoanaChief Medical Officer08/30/202129,962
CHALMERS DEREK TPresident & CEO08/30/2021119,848
VOGELBAUM MARTINDirector06/07/2021112,752
Posner ChristopherDirector06/07/202130,044
Ives Jeffrey L.Director06/07/202132,886
Goncalves JoanaChief Medical Officer04/21/202182,890
Goncalves JoanaChief Medical Officer03/22/202158,950
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D03/05/202160,377
Terrillion ScottSec'y; Chief Compliance & G.C.03/05/202155,558
Goncalves JoanaChief Medical Officer03/05/202155,612
CHALMERS DEREK TPresident & CEO03/05/202155,792
Terrillion ScottSec'y; Chief Compliance & G.C.02/25/202177,397
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D02/25/202196,708
Goncalves JoanaChief Medical Officer02/25/202165,181
CHALMERS DEREK TPresident & CEO02/25/2021226,722
Goncalves JoanaChief Medical Officer02/22/202139,460
Goncalves JoanaChief Medical Officer01/21/202140,240
Terrillion ScottSec'y; Chief Compliance & G.C.12/30/202029,774
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D12/30/202043,024
Goncalves JoanaChief Medical Officer12/30/202019,859
CHALMERS DEREK TPresident & CEO12/30/202092,993
CHALMERS DEREK TPresident & CEO12/28/202080,000
Goncalves JoanaChief Medical Officer12/21/202030,000
CHALMERS DEREK TPresident & CEO12/16/202074,750
CHALMERS DEREK TPresident & CEO12/10/2020114,675
Goncalves JoanaChief Medical Officer11/23/202030,620
Ives Jeffrey L.Director11/19/202039,372
Posner ChristopherDirector11/19/202031,638
Ives Jeffrey L.Director11/19/202039,372
VOGELBAUM MARTINDirector11/17/202096,540
CHALMERS DEREK TPresident & CEO11/17/2020188,784
Goncalves JoanaChief Medical Officer11/10/202030,000
Goncalves JoanaChief Medical Officer10/20/202030,000
CHALMERS DEREK TPresident & CEO09/03/202051,216
CHALMERS DEREK TPresident & CEO08/03/202082,100
CHALMERS DEREK TPresident & CEO07/01/202085,550
Goncalves JoanaChief Medical Officer06/12/2020161,530
CHALMERS DEREK TPresident & CEO06/03/202068,843
CHALMERS DEREK TPresident & CEO06/01/202011,200
Ives Jeffrey L.Director06/01/20209,940
Ives Jeffrey L.Director06/01/202016,000
CHALMERS DEREK TPresident & CEO05/21/202056,000
CHALMERS DEREK TPresident & CEO05/20/202019,200
CHALMERS DEREK TPresident & CEO05/22/20205,936
CHALMERS DEREK TPresident & CEO05/12/202078,864
Ives Jeffrey L.Director05/12/202024,850
Ives Jeffrey L.Director05/12/202040,000
Ives Jeffrey L.Director04/21/202024,850
Ives Jeffrey L.Director04/21/202040,000
Terrillion ScottSec'y; Chief Compliance & G.C.04/21/202042,339
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D04/21/2020200,889
CHALMERS DEREK TPresident & CEO04/21/202098,775
Ives Jeffrey L.Director03/04/202024,850
Ives Jeffrey L.Director03/04/202040,000
Ives Jeffrey L.Director02/03/202024,850
Ives Jeffrey L.Director02/03/202040,575
Ives Jeffrey L.Director01/02/202024,850
Ives Jeffrey L.Director01/02/202040,325
CHALMERS DEREK TPresident & CEO01/02/2020160,500
Terrillion ScottSec'y; Chief Compliance & G.C.12/04/201967,859
Mohindru ManiCFO & Chief Strategy Officer12/04/201981,073
Ives Jeffrey L.Director12/02/201913,300
Ives Jeffrey L.Director12/02/201964,575
CHALMERS DEREK TPresident & CEO12/04/2019182,418
CHALMERS DEREK TPresident & CEO12/02/2019257,900
Ives Jeffrey L.Director11/01/201913,300
Ives Jeffrey L.Director11/01/201951,700
CHALMERS DEREK TPresident & CEO11/01/2019103,950
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D10/25/201979,640
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D10/18/201977,320
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D10/11/201974,800
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D10/04/201976,760
Ives Jeffrey L.Director10/01/201913,300
Ives Jeffrey L.Director10/01/201945,525
CHALMERS DEREK TPresident & CEO10/01/2019182,800
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D09/03/2019458,400
Ives Jeffrey L.Director09/03/201913,300
Ives Jeffrey L.Director09/03/201958,275
CHALMERS DEREK TPresident & CEO09/03/2019116,300
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D08/01/2019464,800
Ives Jeffrey L.Director08/01/201913,300
Ives Jeffrey L.Director08/01/201958,100
CHALMERS DEREK TPresident & CEO08/01/2019232,700
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D07/17/2019247,390
Mohindru ManiCFO & Chief Strategy Officer07/15/2019526,280
Mohindru ManiCFO & Chief Strategy Officer07/15/2019935,775
Ives Jeffrey L.Director07/01/201913,300
Ives Jeffrey L.Director07/01/201954,375
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D07/01/2019438,000
Terrillion ScottSec'y; Chief Compliance & G.C.05/29/201949,238
CHALMERS DEREK TPresident & CEO05/29/2019118,410
Mohindru ManiCFO & Chief Strategy Officer05/29/201953,389
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D05/29/2019241,502
Mohindru ManiCFO & Chief Strategy Officer03/13/2019225,536
Mohindru ManiCFO & Chief Strategy Officer03/13/2019306,704
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D03/13/2019317,073
Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D03/12/201955,948
CHALMERS DEREK TPresident & CEO03/01/2019166,856
Menzaghi Frederique Ph.D.Sr VP-Research & Development02/28/201926,250
Menzaghi Frederique Ph.D.Sr VP-Research & Development02/25/201938,500
CHALMERS DEREK TPresident & CEO02/01/2019299,800
CHALMERS DEREK TPresident & CEO01/04/201975,200
CHALMERS DEREK TPresident & CEO01/02/2019196,950
Menzaghi Frederique Ph.D.Sr VP-Research & Development12/28/201853,879
Terrillion ScottSec'y; Chief Compliance & G.C.12/28/201838,781
CHALMERS DEREK TPresident & CEO12/28/2018198,287
Mohindru ManiCFO & Chief Strategy Officer12/28/201856,475
Menzaghi Frederique Ph.D.Sr VP-Research & Development12/03/201855,080
CHALMERS DEREK TPresident & CEO12/03/2018363,400
Mohindru ManiCFO & Chief Strategy Officer11/15/2018225,551
Mohindru ManiCFO & Chief Strategy Officer11/15/2018296,777
Menzaghi Frederique Ph.D.Sr VP-Research & Development11/01/201882,000
Menzaghi Frederique Ph.D.Sr VP-Research & Development11/01/201856,310
Menzaghi Frederique Ph.D.Sr VP-Research & Development08/06/201822,500
CHALMERS DEREK TPresident & CEO11/01/2018375,600
Stauffer Joseph WilliamChief Medical Officer10/17/2018230,347
Mohindru ManiCFO & Chief Strategy Officer10/17/2018225,551
Mohindru ManiCFO & Chief Strategy Officer10/17/2018323,888
Menzaghi Frederique Ph.D.Sr VP-Research & Development10/01/201871,970
CHALMERS DEREK TPresident & CEO10/01/2018475,800
CHALMERS DEREK TPresident & CEO09/04/2018394,200
Menzaghi Frederique Ph.D.Sr VP-Research & Development09/04/201859,430
Menzaghi Frederique Ph.D.Sr VP-Research & Development08/20/201856,670
CHALMERS DEREK TPresident & CEO07/10/2018412,800
Menzaghi Frederique Ph.D.Sr VP-Research & Development07/02/201857,000
Menzaghi Frederique Ph.D.Sr VP-Research & Development06/01/201846,470
Menzaghi Frederique Ph.D.Sr VP-Research & Development05/23/2018136,710
CHALMERS DEREK TPresident & CEO02/16/201881,000
Menzaghi Frederique Ph.D.Sr VP-Research & Development02/15/201845,060
Menzaghi Frederique Ph.D.Sr VP-Research & Development01/24/2018225,000
CHALMERS DEREK TPresident & CEO01/25/201818,000
CHALMERS DEREK TPresident & CEO01/24/2018187,500
Menzaghi Frederique Ph.D.Sr VP-Research & Development11/07/201749,600
CHALMERS DEREK TPresident & CEO11/03/201749,600
CHALMERS DEREK TPresident & CEO11/01/2017202,560
Menzaghi Frederique Ph.D.VP-Research & Development08/04/201745,000
Schoell JosefChief Financial Officer07/26/20179,000
CHALMERS DEREK TPresident & CEO07/14/201724,800
CHALMERS DEREK TPresident & CEO07/14/2017376,250
Menzaghi Frederique Ph.D.VP-Research & Development07/14/201745,000
Slagel DeanDirector06/29/20176,468,564
RHO Ventures VI LP10% Owner03/31/20179,095,700
Menzaghi Frederique Ph.D.VP-Research & Development04/20/201654,000
VOGELBAUM MARTINDirector03/17/20161,221,368
VOGELBAUM MARTINDirector03/16/2016727,834
RHO Ventures VI LP10% Owner03/16/2016727,834
RHO Ventures VI LP10% Owner03/17/20161,221,368
Schoell JosefChief Financial Officer03/16/201614,740
CHALMERS DEREK TPresident & CEO03/15/201624,800
Menzaghi Frederique Ph.D.VP-Research & Development02/03/20169,000
Menzaghi Frederique Ph.D.VP-Research & Development02/01/201645,250
Lewis Michael EChief Scientific Advisor01/26/201679,374
Slagel DeanDirector01/05/2016531,120
Slagel DeanDirector12/31/2015217,192
CHALMERS DEREK TPresident & CEO01/06/2016215,250
Menzaghi Frederique Ph.D.VP-Research & Development01/04/2016100,800
Slagel DeanDirector01/05/2016531,120
Slagel DeanDirector12/31/2015217,192
Menzaghi Frederique Ph.D.VP-Research & Development12/01/201597,260
Menzaghi Frederique Ph.D.VP-Research & Development11/02/201585,560
Menzaghi Frederique Ph.D.VP-Research & Development10/01/201583,715
Menzaghi Frederique Ph.D.VP-Research & Development09/01/2015130,410
Schoell JosefChief Financial Officer08/18/201566,300
Stauffer Joseph WilliamChief Medical Officer08/04/201537,200
Menzaghi Frederique Ph.D.VP-Research & Development08/03/2015149,870
Menzaghi Frederique Ph.D.VP-Research & Development07/01/201585,540
Lewis Michael EChief Scientific Advisor07/01/201584,675
Lewis Michael EChief Scientific Advisor06/01/201568,989
Slagel DeanDirector05/18/2015832,768
Slagel DeanDirector05/15/2015736,000
Slagel DeanDirector05/19/2015322,660
Lewis Michael EChief Scientific Advisor05/01/201577,268
Lewis Michael EChief Scientific Advisor04/01/201571,894
Menzaghi Frederique Ph.D.VP-Research & Development03/09/20155,000
Lewis Michael EChief Scientific Advisor03/02/201573,419
Schoell JosefChief Financial Officer02/17/2015164,400
Lewis Michael EChief Scientific Advisor02/02/201576,977
Stauffer Joseph WilliamChief Medical Officer12/01/2014100,003
Schoell JosefChief Financial Officer08/14/201410,000
VOGELBAUM MARTINDirector02/05/20142,483,998
RHO Ventures VI LP10% Owner02/05/20142,483,998
ALTA BIOPHARMA PARTNERS III LP10% Owner02/05/20141,240,987
Load More Insider Transactions
FUNDS WITH A POSITION IN CARA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,421,3630.00007%-3.74%Other
FARALLON CAPITAL MANAGEMENT LLC1,556,2510.00642%No changeEvent Driven, Value
RENAISSANCE TECHNOLOGIES LLC1,332,4780.00191%91.17%Other
GEODE CAPITAL MANAGEMENT, LLC1,021,5990.00009%1.25%Other
AQR CAPITAL MANAGEMENT LLC28,8180.00004%-96.52%Other
D. E. SHAW & CO., INC.141,1500.00011%-3.88%Other
TUDOR INVESTMENT CORP ET AL93,1160.00054%No changeEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR CARA THERAPEUTICS INC
STOCK BUYBACKS FOR CARA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.20%
1Q
03/31/2024
09/30/2023
0.65%
2Q
03/31/2024
06/30/2023
1.08%
3Q
03/31/2024
03/31/2023
1.33%
4Q
03/31/2024
12/31/2022
1.53%
5Q
03/31/2024
09/30/2022
1.60%
6Q
03/31/2024
06/30/2022
1.82%
7Q
03/31/2024
03/31/2022
2.02%
8Q
03/31/2024
12/31/2021
3.43%
9Q
03/31/2024
09/30/2021
8.93%
10Q
03/31/2024
06/30/2021
9.05%
11Q
03/31/2024
03/31/2021
9.36%
12Q
03/31/2024
12/31/2020
6.52%
13Q
03/31/2024
09/30/2020
16.43%
14Q
03/31/2024
06/30/2020
16.64%
15Q
03/31/2024
03/31/2020
16.83%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.20%
1Q
09/30/2023
0.65%
2Q
06/30/2023
1.08%
3Q
03/31/2023
1.33%
4Q
12/31/2022
1.53%
5Q
09/30/2022
1.60%
6Q
06/30/2022
1.82%
7Q
03/31/2022
2.02%
8Q
12/31/2021
3.43%
9Q
09/30/2021
8.93%
10Q
06/30/2021
9.05%
11Q
03/31/2021
9.36%
12Q
12/31/2020
6.52%
13Q
09/30/2020
16.43%
14Q
06/30/2020
16.64%
15Q
03/31/2020
16.83%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CARA THERAPEUTICS INC
LOADING...